Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anjasu Paul, Md. Belayet Hasan Limon, Md. Mobarok Hossain & Md. Thosif Raza. (2023) An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines. Journal of Biomolecular Structure and Dynamics 41:7, pages 3025-3041.
Read now
Read now
Articles from other publishers (20)
H. Matthew Berns, Dawn E. Watkins‐Chow, Sizhu Lu, Pakavarin Louphrasitthiphol, Tongwu Zhang, Kevin M. Brown, Pedro Moura‐Alves, Colin R. Goding & William J. Pavan. (2023)
Single‐cell profiling of
MC1R
‐inhibited melanocytes
. Pigment Cell & Melanoma Research.
Crossref
Crossref
Xiaoyu Li, Daniel C Moreira, Asim K Bag, Ibrahim Qaddoumi, Sahaja Acharya & Jason Chiang. (2023) The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma. Neuro-Oncology 25:4, pages 750-760.
Crossref
Crossref
Saif F. Khan, Carly A. Burmeister, David J. Scott, Musalula Sinkala, Amsha Ramburan, Hue-Tsi Wu, Georgia Schäfer, Arieh A. Katz & Sharon Prince. (2023) TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling. Molecular Cancer Research 21:4, pages 345-358.
Crossref
Crossref
Lifu Huang, Xianjun Zhang, Feiping Li & Xiaohong Wang. (2022) MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer. Computational and Mathematical Methods in Medicine 2022, pages 1-10.
Crossref
Crossref
Victoria Damerell, Melvin Anyasi Ambele, Shanel Salisbury, Alexis Neumann-Mufweba, Chrisna Durandt, Michael Sean Pepper & Sharon Prince. (2022) The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. Frontiers in Oncology 11.
Crossref
Crossref
Jade Peres, Victoria Damerell, Jagat Chauhan, Ana Popovic, Pierre-Yves Desprez, Marie-Dominique Galibert, Colin R. Goding & Sharon Prince. (2021) TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF. Journal of Investigative Dermatology 141:9, pages 2250-2260.e2.
Crossref
Crossref
Victoria Damerell, Michael S. Pepper & Sharon Prince. (2021) Molecular mechanisms underpinning sarcomas and implications for current and future therapy. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Zhecun Wang, Yunling Qi, Rui Wang, Weibin Wu, Zilun Li, Mian Wang, Ruiming Liu, Chunxiang Zhang, Wen Li & Shenming Wang. (2020) IGFBP6 regulates vascular smooth muscle cell proliferation and morphology via cyclin E–CDK2. Journal of Cellular Physiology 235:12, pages 9538-9556.
Crossref
Crossref
Danica Sims, Hapiloe Mabaruti Maranyane, Victoria Damerell, Dhirendra Govender, Ashwin W. Isaacs, Jade Peres & Sharon Prince. (2020) The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal Rhabdomyosarcoma. Cancers 12:2, pages 501.
Crossref
Crossref
Saif F. Khan, Victoria Damerell, Rehana Omar, Michelle Du Toit, Mohsin Khan, Hapiloe Mabaruti Maranyane, Mihlali Mlaza, Jenna Bleloch, Claire Bellis, Bianca D.B. Sahm, Jade Peres, K.N. ArulJothi & Sharon Prince. (2020) The roles and regulation of TBX3 in development and disease. Gene 726, pages 144223.
Crossref
Crossref
Yongjiu Huang, Hongmei Zhu, Xiaohui Ji, Yin Chen, Yanhui Zhang, Ruofei Huang, Jin Xie & Pin Dong. (2019) TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis. Oncology Letters.
Crossref
Crossref
Saeb Aliwaini, Abdel Lubbad, Ahmed Shourfa, Hosam Hamada, Basim Ayesh, Husam Abu Tayem, Ayman Abu Mustafa, Fayek Abu Rouk, Moen Redwan & Mohamed Al‑Najjar. (2018) Overexpression of TBX3 transcription factor as a potential diagnostic marker for breast cancer. Molecular and Clinical Oncology.
Crossref
Crossref
Xiaomeng Li, Xianhui Ruan, Peitao Zhang, Yang Yu, Ming Gao, Shukai Yuan, Zewei Zhao, Jie Yang & Li Zhao. (2018) TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression. Oncogene 37:21, pages 2773-2792.
Crossref
Crossref
Jie Ji, Yin Yin, Huanyu Ju, Xiaoliang Xu, Wei Liu, Qiang Fu, Jiaojiao Hu, Xudong Zhang & Beicheng Sun. (2018) Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC. Cell Death & Disease 9:5.
Crossref
Crossref
Minxia Ke, Quan He, Danping Hong, Ouyang Li, Mengyi� Zhu, Wen‑Bin Ou, Yulong He & Yuehong Wu. (2018) Leukemia inhibitory factor regulates marmoset induced pluripotent stem cell proliferation via a PI3K/Akt‑dependent Tbx‑3 activation pathway. International Journal of Molecular Medicine.
Crossref
Crossref
Jade Peres, Eliza M. Kwesi-Maliepaard, Florian Rambow, Lionel Larue & Sharon Prince. (2017) The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor. Cancer Letters 405, pages 111-119.
Crossref
Crossref
Ryo Ichijo, Hiroki Kobayashi, Saori Yoneda, Yui Iizuka, Hirokazu Kubo, Shigeru Matsumura, Satsuki Kitano, Hitoshi Miyachi, Tetsuya Honda & Fumiko Toyoshima. (2017) Tbx3-dependent amplifying stem cell progeny drives interfollicular epidermal expansion during pregnancy and regeneration. Nature Communications 8:1.
Crossref
Crossref
Tarryn Willmer, Aretha Cooper, Jade Peres, Rehana Omar & Sharon Prince. (2017) The T-Box transcription factor 3 in development and cancer. BioScience Trends 11:3, pages 254-266.
Crossref
Crossref
Tarryn Willmer, Shannagh Hare, Jade Peres & Sharon Prince. (2016) The T-box transcription factor TBX3 drives proliferation by direct repression of the p21WAF1 cyclin-dependent kinase inhibitor. Cell Division 11:1.
Crossref
Crossref
T Willmer, A Cooper, D Sims, D Govender & S Prince. (2016) The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes. Oncogenesis 5:2, pages e199-e199.
Crossref
Crossref